SCHEMBL6975324

SCHEMBL6975324

COc1ccc(N)cc1N1CCN(c2ccccc2C=O)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
DRD2 P14416 5/20 0.46
DRD3 P35462 3/20 0.46
LMNA P02545 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HTR2A P28223 3/20 0.45
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
GAA P10253 3/20 0.43
USP2 O75604 1/20 0.43
GLA P06280 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6977707 0.80 MAPT (0.62) ALDH1A1MAPTDRD2LMNAKDM4E
SCHEMBL1397389 0.77 DRD2 (0.60) ALDH1A1MAPTDRD2DRD3LMNA
SCHEMBL14320628 0.77 MAPT (0.59) ALDH1A1MAPTDRD2DRD3LMNA
Hydrochloric Acid SCHEMBL6343779 0.76 KDM4E (0.59) ALDH1A1MAPTDRD2DRD3LMNA
Hydrochloric Acid SCHEMBL6345252 0.76 KDM4E (0.59) ALDH1A1MAPTDRD2DRD3LMNA
SCHEMBL6980846 0.75 ALDH1A1 (0.44) ALDH1A1MAPTDRD2DRD3LMNA
SCHEMBL5701472 0.75 ALDH1A1 (0.57) ALDH1A1MAPTLMNAKDM4EGAA
SCHEMBL6355490 0.75 ALDH1A1 (0.60) ALDH1A1MAPTDRD2LMNAKDM4E
SCHEMBL6975327 0.74 MEN1 (0.62) ALDH1A1MAPTDRD2LMNAKDM4E
SCHEMBL8984896 0.74 ALDH1A1 (0.53) ALDH1A1MAPTLMNAKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946539-B1 SULPHONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS SMITHKLINE BEECHAM PLC (GB) 2003-08-13 EP disclosed
US-6599904-B2 5-HT6 receptor antagonists are believed to be of potential use in the treatment of certain CNS disorders; cognitive memory enhancement SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-29 US disclosed